The Kidney-Gut Axis: Implications for Nutrition Care

Journal of Renal Nutrition

Volumn 25, Issue 5, 2015, Pages 399-403

  Rossi, Megan ^a,b,c   Johnson, David W ^a,b,c   Campbell, Katrina L ^a,c,d  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c TRANSLATIONAL RESEARCH INSTITUTE   (Australia)

^d BOND UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS);

PREBIOTIC AGENT; PROBIOTIC AGENT; PROTEIN INTAKE; SYNBIOTIC AGENT;

ADMINISTRATION AND DOSAGE; CHRONIC KIDNEY FAILURE; DIET; DIET THERAPY; DIETARY FIBER; GASTROINTESTINAL TRACT; INFLAMMATION; INTESTINE FLORA; KIDNEY; METABOLISM; MICROBIOLOGY; PROTEIN INTAKE;

DIET; DIETARY FIBER; DIETARY PROTEINS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; INFLAMMATION; KIDNEY; PREBIOTICS; PROBIOTICS; RENAL INSUFFICIENCY, CHRONIC; SYNBIOTICS;

EID: 84940450077     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2015.01.017     Document Type: Article

References (63)

1. Sekirov I., Russell S.L., Antunes L.C., Finlay B.B. Gut microbiota in health and disease. Physiol Rev 2010, 90:859-904.
2. Meijers B.K., Evenepoel P. The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. Nephrol Dial Transplant 2011, 26:759-761.
3. Ramezani A., Raj D.S. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 2014, 25:657-670.
4. David L.A., Maurice C.F., Carmody R.N., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505:559-563.
5. Nugent R.A., Fathima S.F., Feigl A.B., Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 2011, 118:c269-c277.
6. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214. Human Microbiome Project C.
7. Wong J., Piceno Y.M., Desantis T.Z., Pahl M., Andersen G.L., Vaziri N.D. Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. Am J Nephrol 2014, 39:230-237.
8. Vaziri N.D., Wong J., Pahl M., et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int 2013, 83:308-315.
9. Ash S., Campbell K.L., Bogard J., Millichamp A. Nutrition prescription to achieve positive outcomes in chronic kidney disease: a systematic review. Nutrients 2014, 6:416-451.
10. Wong J.M., de Souza R., Kendall C.W., Emam A., Jenkins D.J. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006, 40:235-243.
11. Vinolo M.A., Rodrigues H.G., Nachbar R.T., Curi R. Regulation of inflammation by short chain fatty acids. Nutrients 2011, 3:858-876.
12. Rossi M., Campbell K.L., Johnson D.W. Indoxyl sulphate and p-cresyl sulphate: therapeutically modifiable nephrovascular toxins. OA Nephrology 2013, 1:13.
13. Evenepoel P., Meijers B.K., Bammens B.R., Verbeke K. Uremic toxins originating from colonic microbial metabolism. Kidney Int Suppl 2009, 76:S12-S19.
14. Prosky L. What is dietary fiber?. J AOAC Int 2000, 83:985-987.
15. Howlett J.F., Betteridge V.A., Champ M., Craig S.A., Meheust A., Jones J.M. The definition of dietary fiber-discussions at the Ninth Vahouny Fiber Symposium: building scientific agreement. Food Nutr Res 2010, 54:1-9.
16. Jones J.M. CODEX-aligned dietary fiber definitions help to bridge the 'fiber gap'. Nutr J 2014, 13:34.
17. Burger-van Paassen N., Vincent A., Puiman P.J., et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J 2009, 420:211-219.
18. McIntyre C.W., Harrison L.E., Eldehni M.T., et al. Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol 2011, 6:133-141.
19. Birkett A., Muir J., Phillips J., Jones G., O'Dea K. Resistant starch lowers fecal concentrations of ammonia and phenols in humans. Am J Clin Nutr 1996, 63:766-772.
20. Krishnamurthy V.M., Wei G., Baird B.C., et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int 2012, 81:300-306.
21. Gilani G.S., Cockell K.A., Sepehr E. Effects of antinutritional factors on protein digestibility and amino acid availability in foods. J AOAC Int 2005, 88:967-987.
22. Silvester K.R., Cummings J.H. Does digestibility of meat protein help explain large bowel cancer risk?. Nutr Cancer 1995, 24:279-288.
23. Evenepoel P., Claus D., Geypens B., et al. Amount and fate of egg protein escaping assimilation in the small intestine of humans. Am J Physiol 1999, 277(5 Pt 1):G935-G943.
24. Bammens B., Verbeke K., Vanrenterghem Y., Evenepoel P. Evidence for impaired assimilation of protein in chronic renal failure. Kidney Int 2003, 64:2196-2203.
25. Evenepoel P., Claus D., Geypens B., et al. Evidence for impaired assimilation and increased colonic fermentation of protein, related to gastric acid suppression therapy. Aliment Pharmacol Ther 1998, 12:1011-1019.
26. Bammens B., Evenepoel P., Verbeke K., Vanrenterghem Y. Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept. Am J Clin Nutr 2004, 80:1536-1543.
27. Strid H., Simren M., Johansson A.C., Svedlund J., Samuelsson O., Bjornsson E.S. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transpl 2002, 17:1434-1439.
28. Haas L.F. Pedanius Dioscorides (born about AD40, died about AD90). J Neurol Neurosurg Psychiatry 1996, 60:427.
29. Twiss E.E., Kolff W.J. Treatment of uremia by perfusion of an isolated intestinal loop; survival for forty-six days after removal of the only functioning kidney. J Am Med Assoc 1951, 146:1019-1022.
30. Su B., Liu H., Li J., et al. Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus. J Diabetes 2014, [published online ahead of print October 18 2014], Accessed November 24, 2014. http://www.ncbi.nlm.nih.gov/pubmed/25327485.
31. Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008, 6:e280.
32. Chow J. Probiotics and prebiotics: a brief overview. J Ren Nutr 2002, 12:76-86.
33. Zirker L. Probiotic use in chronic kidney disease patients. J Ren Nutr 2014, 24:e47-e49.
34. Poesen R., Meijers B., Evenepoel P. The colon: an overlooked site for therapeutics in dialysis patients. Semin Dial 2013, 26:323-332.
35. Kellow N.J., Coughlan M.T., Reid C.M. Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials. Br J Nutr 2014, 111:1147-1161.
36. Dong J.Y., Szeto I.M., Makinen K., et al. Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 2013, 110:1188-1194.
37. Sanchez M., Darimont C., Drapeau V., et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 2014, 111:1507-1519.
38. Reid G., Bruce A.W., Fraser N., Heinemann C., Owen J., Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001, 30:49-52.
39. Punaro G.R., Maciel F.R., Rodrigues A.M., et al. Kefir administration reduced progression of renal injury in STZ-diabetic rats by lowering oxidative stress. Nitric Oxide 2014, 37:53-60.
40. Sari E.K., Bakir B., Aydin B.D., Sozmen M. The effects of kefir, koumiss, yogurt and commercial probiotic formulations on PPARalpha and PPAR-beta/delta expressions in mouse kidney. Biotech Histochem 2014, 89:287-295.
41. Dheer R., Chordia T., Pechenyak B., et al. Kibow biotics is preferred and superior to yogurt for uremia applications. J Am Soc Nephrol 2004, 15:769A.
42. Saxelin M., Lassig A., Karjalainen H., et al. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese. Int J Food Microbiol 2010, 144:293-300.
43. Westenbrink S., Brunt K., van der Kamp J.W. Dietary fibre: challenges in production and use of food composition data. Food Chem 2013, 140:562-567.
44. Organization FaA Guidelines for the evaluation of probiotics in food. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food 2002, Food and Agriculture Organization, London.
45. Gibson G.R., Probert H.M., Loo J.V., Rastall R.A., Roberfroid M.B. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004, 17:259-275.
46. Elli M., Callegari M.L., Ferrari S., et al. Survival of yogurt bacteria in the human gut. Appl Environ Microbiol 2006, 72:5113-5117.
47. Muir J.G., Shepherd S.J., Rosella O., Rose R., Barrett J.S., Gibson P.R. Fructan and free fructose content of common Australian vegetables and fruit. J Agric Food Chem 2007, 55:6619-6627.
48. Lopitz-Otsoa F., Rementeria A., Elguezabal N., Garaizar J. Kefir: a symbiotic yeasts-bacteria community with alleged healthy capabilities. Rev Iberoam Micol 2006, 23:67-74.
49. Marsh A.J., O'Sullivan O., Hill C., Ross R.P., Cotter P.D. Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples. Food Microbiol 2014, 38:171-178.
50. Biesiekierski J.R., Rosella O., Rose R., et al. Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals. J Hum Nutr Diet 2011, 24:154-176.
51. Cheigh H.S., Park K.Y. Biochemical, microbiological, and nutritional aspects of kimchi (Korean fermented vegetable products). Crit Rev Food Sci Nutr 1994, 34:175-203.
52. Ibe S., Kumada K., Yoshida K., Otobe K. Natto (fermented soybean) extract extends the adult lifespan of Caenorhabditis elegans. Biosci Biotechnol Biochem 2013, 77:392-394.
53. Muir J.G., Rose R., Rosella O., et al. Measurement of short-chain carbohydrates in common Australian vegetables and fruits by high-performance liquid chromatography (HPLC). J Agric Food Chem 2009, 57:554-565.
54. Manley K.J., Fraenkel M.B., Mayall B.C., Power D.A. Probiotic treatment of vancomycin-resistant enterococci: a randomised controlled trial. Med J Aust 2007, 186:454-457.
55. Taki K., Takayama F., Niwa T. Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients. J Ren Nutr 2005, 15:77-80.
56. Miranda Alatriste P.V., Urbina Arronte R., Gomez Espinosa C.O. Espinosa Cuevas Mde L. Effect of probiotics on human blood urea levels in patients with chronic renal failure. Nutr Hosp 2014, 29:582-590.
57. Ranganathan N., Friedman E.A., Tam P., Rao V., Ranganathan P., Dheer R. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada. Curr Med Res Opin 2009, 25:1919-1930.
58. Hida M., Aiba Y., Sawamura S., Suzuki N., Satoh T., Koga Y. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 1996, 74:349-355.
59. Guida B., Germano R., Trio R., et al. Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial. Nutr Metab Cardiovasc Dis 2014, 24:1043-1049.
60. Dunn S.R., Simenhoff M.L., Ahmed K.E., et al. Effect of Oral Administration of Freeze-Dried Lactobacillus acidophilus on Small Bowel Bacterial Overgrowth in Patients with End Stage Kidney Disease: Reducing Uremic Toxins and Improving Nutrition. Int Dairy J 1998, 8:545-553.
61. Ogawa T., Shimada M., Nagano N., et al. Oral administration of Bifidobacterium longum in a gastro-resistant seamless capsule decreases serum phosphate levels in patients receiving haemodialysis. Clin Kidney J 2012, 5:373-374.
62. Ranganathan N., Ranganathan P., Friedman E.A., et al. Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Adv Ther 2010, 27:634-647.
63. Campieri C., Campieri M., Bertuzzi V., et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 2001, 60:1097-1105.